Glycosphingolipids of an alveolar rhabdomyosarcoma and normal human muscle
Neurochemical Pathology · 1984
DOI: 10.1007/bf02834169 ↗At a glance
Fallbericht in Neurochemical Pathology, 1984. Written by K C Leskawa and 3 co-authors. Cited 7 times so far (Crossref); 33 references.
Abstract (original language)
The distribution of neutral, or asialosyl-, glycosphingolipids and gangliosides in a rhabdomyosarcoma of alveolar type have been studied. Histologically, this muscle tumor is composed primarily of two cell types: one with oval or round hyperchromatic nuclei and very little cytoplasm, and one a giant cell, with multiple, peripherally placed nuclei and weakly staining eosinophillic cytoplasm. In comparing glycolipids of the rhabdomyosarcoma with normal muscle from the same leg, the striking alteration in the tumor was a virtual disappearance of ganglioside GM2. There was also a slight increase in GM3 and a decrease in GD1a. The asialosyl derivative of GM2 (GalNac-Gal-Glc-Cer) was markedly increased in the tumor. A loss of glucosylceramide was also observed. The results are discussed in terms of glycolipid metabolic changes in muscle oncogenesis and their implications.
Subjects
MeSH terms (MEDLINE)
Substances
Cite
APA
Leskawa, K. C., Buse, P. E., Hogan, E. L., & Garvin, A. J. (1984). Glycosphingolipids of an alveolar rhabdomyosarcoma and normal human muscle. Neurochemical Pathology. https://doi.org/10.1007/bf02834169
Vancouver
Leskawa KC, Buse PE, Hogan EL, Garvin AJ. Glycosphingolipids of an alveolar rhabdomyosarcoma and normal human muscle. Neurochemical Pathology. 1984. doi:10.1007/bf02834169
BibTeX
@article{Leskawa1984,
author = {Leskawa, K C and Buse, P E and Hogan, E L and Garvin, A J},
title = {Glycosphingolipids of an alveolar rhabdomyosarcoma and normal human muscle},
journal = {Neurochemical Pathology},
year = {1984},
doi = {10.1007/bf02834169}
}
EUVIMED